Dear Editor and colleagues, We read with great interest the article entitled “Factors associated with unknown primary status in head and neck squamous cell carcinoma” published in your journal, that gives the opportunity to discuss such a hot topic in head and neck oncology. The paper presents a very large case series well-stratified based on epidemiological data and suggests several prognostic factors in patients with unknown primary head and neck cancer. We believe that additional details, focusing on the analysis and comparison of patients according to lymph node staging, not reported in Table 3, would have enhanced the exhaustiveness of the study. It is unclear if the staging (especially regarding lymph node status) took into account the distinction between HPV-related and non-HPV-related lymph node metastases, which is critical for a thorough assessment of the outcomes. In the Eighth Edition AJCC Cancer Staging the clinical N staging categories for p16-positive disease is different since HPV related or p16-positive oropharyngeal cancer (OPC) is a different entity and it usually shows excellent response to treatment even in patients with advanced stage disease. The literature emphasizes the significance of lymph node staging, particularly in case of unknown primary tumors, as it serves as an essential prognostic factor for disease progression. It is evident that the main prognostic factor in such a group of patients is the lymph node metastasis and not the unknown primary disease. Accordingly, J. Califano et al. [1] previously highlighted the potential of regression from T to severe dysplasia in oropharyngeal T unknown diseases. More recently, the spontaneous regression of the primary tumor site is among the theories of carcinogenesis, along with subclinical dormancy and undetectable location, as mentioned by Meulemans et al. [2], further emphasizing the importance of N in determining the outcome. Thus, neglecting the role of lymph node metastases in disease development would be like ignoring “the elephant in the room”. In our opinion it would be useful to compare the outcomes of the groups with unknown T (remaining) and identified T by stratifying the data according to N classification. This analysis could provide insight into whether prognosis is primarily influenced by unknown T status, N staging, or a combination of both factors. Another aspect to consider is the use of surgery, particularly Transoral Robotic Surgery (TORS), in identifying the primary site. Certainly, the search for the primary tumor in Cancer of Unknown Primary (CUP) is a crucial aspect of the treatment regimen, which can be influenced by the identification of the primary tumor. Furthermore, several studies have confirmed that identifying the primary tumor may enhance post- treatment outcomes, and Trans Oral Robotic Surgery (TORS) can be employed for this purpose [3]. However, it is essential to note that this surgical procedure is associated with complications and is frequently accompanied by temporary tracheostomy [4]. Considering the high level of specialization it requires and its risks, can it truly be used routinely for this type of application? This issue seems to be far from being clarified.
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room? / Fancello, G., Jiang, S., Licci, G., Gallo, O.. - In: ORAL ONCOLOGY. - ISSN 1368-8375. - ELETTRONICO. - 151:(2024), pp. 0-0. [10.1016/j.oraloncology.2024.106727]
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?
Fancello, Giuseppe;Jiang, Serena;Licci, Giuseppe;Gallo, Oreste
2024
Abstract
Dear Editor and colleagues, We read with great interest the article entitled “Factors associated with unknown primary status in head and neck squamous cell carcinoma” published in your journal, that gives the opportunity to discuss such a hot topic in head and neck oncology. The paper presents a very large case series well-stratified based on epidemiological data and suggests several prognostic factors in patients with unknown primary head and neck cancer. We believe that additional details, focusing on the analysis and comparison of patients according to lymph node staging, not reported in Table 3, would have enhanced the exhaustiveness of the study. It is unclear if the staging (especially regarding lymph node status) took into account the distinction between HPV-related and non-HPV-related lymph node metastases, which is critical for a thorough assessment of the outcomes. In the Eighth Edition AJCC Cancer Staging the clinical N staging categories for p16-positive disease is different since HPV related or p16-positive oropharyngeal cancer (OPC) is a different entity and it usually shows excellent response to treatment even in patients with advanced stage disease. The literature emphasizes the significance of lymph node staging, particularly in case of unknown primary tumors, as it serves as an essential prognostic factor for disease progression. It is evident that the main prognostic factor in such a group of patients is the lymph node metastasis and not the unknown primary disease. Accordingly, J. Califano et al. [1] previously highlighted the potential of regression from T to severe dysplasia in oropharyngeal T unknown diseases. More recently, the spontaneous regression of the primary tumor site is among the theories of carcinogenesis, along with subclinical dormancy and undetectable location, as mentioned by Meulemans et al. [2], further emphasizing the importance of N in determining the outcome. Thus, neglecting the role of lymph node metastases in disease development would be like ignoring “the elephant in the room”. In our opinion it would be useful to compare the outcomes of the groups with unknown T (remaining) and identified T by stratifying the data according to N classification. This analysis could provide insight into whether prognosis is primarily influenced by unknown T status, N staging, or a combination of both factors. Another aspect to consider is the use of surgery, particularly Transoral Robotic Surgery (TORS), in identifying the primary site. Certainly, the search for the primary tumor in Cancer of Unknown Primary (CUP) is a crucial aspect of the treatment regimen, which can be influenced by the identification of the primary tumor. Furthermore, several studies have confirmed that identifying the primary tumor may enhance post- treatment outcomes, and Trans Oral Robotic Surgery (TORS) can be employed for this purpose [3]. However, it is essential to note that this surgical procedure is associated with complications and is frequently accompanied by temporary tracheostomy [4]. Considering the high level of specialization it requires and its risks, can it truly be used routinely for this type of application? This issue seems to be far from being clarified.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



